Neuromuscular Blockade Complications

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-10-04
Clinical Trial Update: Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine [Phase 4]
Phase 4 trial comparing residual paralysis reversal with routine neostigmine versus half-dose sugammadex plus routine neostigmine in neuromu…